INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2012
|
Total net assets |
£128.0m |
|
NAV per share |
230.8p |
|
Share price |
207.0p |
|
Total value of unquoted investments |
£21.3m |
|
Total number of portfolio companies |
66 |
|
Cash |
6% NAV |
|
Cash committed and reserved to unquoted investments |
(5)% NAV |
|
Portfolio companies with < 1 year of cash |
19.91% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen Celgene Aptiv |
7.7 6.8 4.4 |
|
Gilead |
4.1 |
|
Pharmaxis |
3.5 |
|
Alexion |
3.5 |
|
Insulet |
2.8 |
|
Onyx |
2.7 |
|
Jazz Life Technologies |
2.6 2.4 |
|
|
----------- |
|
Total |
40.5 |
|
Geographical Allocation |
% |
|
United States & Canada |
81 |
|
Europe |
9 |
|
Australia |
4 |
|
Cash |
6 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
77 |
|
Unquoted |
17 |
|
Cash |
6 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
16 NOVEMBER 2012